» Articles » PMID: 25136377

The Cognitive Neuropsychological Phenotype of Carriers of the FMR1 Premutation

Overview
Publisher Biomed Central
Specialties Neurology
Psychiatry
Date 2014 Aug 20
PMID 25136377
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting a subset of carriers of the FMR1 (fragile X mental retardation 1) premutation. Penetrance and expression appear to be significantly higher in males than females. Although the most obvious aspect of the phenotype is the movement disorder that gives FXTAS its name, the disorder is also accompanied by progressive cognitive impairment. In this review, we address the cognitive neuropsychological and neurophysiological phenotype for males and females with FXTAS, and for male and female unaffected carriers. Despite differences in penetrance and expression, the cognitive features of the disorder appear similar for both genders, with impairment of executive functioning, working memory, and information processing the most prominent. Deficits in these functional systems may be largely responsible for impairment on other measures, including tests of general intelligence and declarative learning. FXTAS is to a large extent a white matter disease, and the cognitive phenotypes observed are consistent with what some have described as white matter dementia, in contrast to the impaired cortical functioning more characteristic of Alzheimer's disease and related disorders. Although some degree of impaired executive functioning appears to be ubiquitous among persons with FXTAS, the data suggest that only a subset of unaffected carriers of the premutation - both female and male - demonstrate such deficits, which typically are mild. The best-studied phenotype is that of males with FXTAS. The manifestations of cognitive impairment among asymptomatic male carriers, and among women with and without FXTAS, are less well understood, but have come under increased scrutiny.

Citing Articles

Reduced Respiratory Sinus Arrhythmia in Infants with the Premutation.

Chase A, Hamrick L, Arnold H, Smith J, Hantman R, Cortez K Int J Mol Sci. 2025; 26(5).

PMID: 40076819 PMC: 11900448. DOI: 10.3390/ijms26052186.


Language use predicts symptoms of fragile X-associated tremor/ataxia syndrome in men and women with the FMR1 premutation.

Maltman N, Sterling A, Santos E, Hagerman R Sci Rep. 2024; 14(1):20707.

PMID: 39237554 PMC: 11377817. DOI: 10.1038/s41598-024-70810-y.


Apolipoproteine and Gene Variants Do Not Affect the Penetrance of Fragile X-Associated Tremor/Ataxia Syndrome.

Winarni T, Hwang Y, Rivera S, Hessl D, Durbin-Johnson B, Utari A Int J Mol Sci. 2024; 25(15).

PMID: 39125677 PMC: 11312271. DOI: 10.3390/ijms25158103.


Cognitive status correlates of subclinical action tremor in female carriers of FMR1 premutation.

Loesch D, Atkinson A, Hall D, Tassone F, Stimpson P, Storey E Front Neurol. 2024; 15:1401286.

PMID: 38903175 PMC: 11188871. DOI: 10.3389/fneur.2024.1401286.


Dementia in Rare Genetic Neurodevelopmental Disorders: A Systematic Literature Review.

Kwetsie H, van Schaijk M, van der Lee S, Maes-Festen D, Ten Hoopen L, van Haelst M Neurology. 2024; 102(11):e209413.

PMID: 38759134 PMC: 11175636. DOI: 10.1212/WNL.0000000000209413.


References
1.
Tassone F, Adams J, Berry-Kravis E, Cohen S, Brusco A, Leehey M . CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). Am J Med Genet B Neuropsychiatr Genet. 2007; 144B(4):566-9. DOI: 10.1002/ajmg.b.30482. View

2.
Hunter J, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K . Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(5):549-59. PMC: 3696495. DOI: 10.1002/ajmg.b.32061. View

3.
Yang J, Chan S, Khan S, Schneider A, Nanakul R, Teichholtz S . Neural substrates of executive dysfunction in fragile X-associated tremor/ataxia syndrome (FXTAS): a brain potential study. Cereb Cortex. 2012; 23(11):2657-66. PMC: 3792740. DOI: 10.1093/cercor/bhs251. View

4.
Schneider A, Ballinger E, Chavez A, Tassone F, Hagerman R, Hessl D . Prepulse inhibition in patients with fragile X-associated tremor ataxia syndrome. Neurobiol Aging. 2010; 33(6):1045-53. PMC: 3044775. DOI: 10.1016/j.neurobiolaging.2010.09.002. View

5.
Bourgeois J, Farzin F, Brunberg J, Tassone F, Hagerman P, Zhang L . Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine. J Neuropsychiatry Clin Neurosci. 2006; 18(2):171-7. DOI: 10.1176/jnp.2006.18.2.171. View